PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference.
The fireside chat will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 AM Eastern Time on the Investors section of the Agile Therapeutics website at
www.agiletherapeutics.com
, under the
Events & Presentations
tab. The archived webcast will be available for 30 days.
About Agile Therapeutics, Inc.
Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla
®
, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion
®
, which is designed to allow drug delivery through the skin. For more information, please visit the company website at
www.agiletherapeutics.com
. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Follow Agile on
LinkedIn
and Twitter:
@AgileTher
.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
[email protected]
